Anti-Inflammatory Treatment After Discharge Home from the Emergency Department in Adults with Acute Asthma

Journal of Emergency Medicine

Volumn 37, Issue 2 SUPPL., 2009, Pages

  Krishnan, Jerry A ^a   Nowak, Richard ^b   Davis, Steven Q ^c   Schatz, Michael ^d  

^a University of Chicago   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c Texas Pulmonary and Critical Care Consultants PA   (United States)

^d KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE; BUDESONIDE; DEXAMETHASONE; FLUNISOLIDE; FLUTICASONE; METHYLPREDNISOLONE; METHYLPREDNISOLONE ACETATE; PLACEBO; PREDNISOLONE; PREDNISONE; TELITHROMYCIN; TRIAMCINOLONE DIACETATE; ZAFIRLUKAST;

ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; EMERGENCY TREATMENT; EMERGENCY WARD; FORCED EXPIRATORY VOLUME; HOSPITAL DISCHARGE; HUMAN; LUNG FUNCTION; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RELAPSE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

ADRENAL CORTEX HORMONES; ADULT; ASTHMA; EMERGENCY SERVICE, HOSPITAL; HUMANS; LEUKOTRIENE ANTAGONISTS; PATIENT DISCHARGE; PATIENT EDUCATION AS TOPIC; SELF ADMINISTRATION;

EID: 68349164744     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2009.06.107     Document Type: Article

References (37)

1. Rowe B.H., Spooner C.H., Ducharme F.M., Bretzlaff J.A., and Bota G.W. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev 1 (2001) CD000195
2. National Asthma Education Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (2007). http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm Accessed May 30, 2009
3. Silverman R.A., Nowak R.M., Korenblat P.E., Skobeloff E., Chen Y., Bonuccelli C.M., et al. Zafirlukast treatment for acute asthma. Chest 126 (2004) 1480-1489
4. Chan J.S., Cowie R.L., Lazarenko G.C., Little C., Scott S., and Ford G.T. Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma. Can Respir J 8 (2001) 147-152
5. Edmonds M.L., Camargo C.A., Saunders L.D., Brenner B.E., and Rowe B.H. Inhaled steroids in acute asthma following emergency department discharge. Cochrane Database Syst Rev 3 (2000) CD002316
6. Rowe B.H., Edmonds M.L., Spooner C.H., Diner B., and Camargo Jr. C.A. Corticosteroid therapy for acute asthma. Respir Med 98 (2004) 275-294
7. Edmonds M.L., Camargo Jr. C.A., Brenner B.E., and Rowe B.H. Replacement of oral corticosteroids with inhaled corticosteroids in the treatment of acute asthma following emergency department discharge: a meta-analysis. Chest 21 (2002) 1798-1805
8. Schatz M., Kazzi A.A.N., Brenner B., Camargo Jr. C.A., Corbridge T., Krishnan J.A., Nowak R., and Rachelefsky G. Introduction. J Emerg Med 37 Suppl (2009) S1-S5
9. Hoffman I.B., and Fiel S.B. Oral vs repository corticosteroid therapy in acute asthma. Chest 93 (1988) 11-13
10. Lee C.H., Lee C.J., Lan R.S., Tsai Y.H., Chiang Y.C., Wang W.J., et al. Repository dexamethasone in the treatment of acute bronchial asthma. Changgeng Yi Xue Za Zhi 16 (1993) 25-29
11. Shuckman H., DeJulius D.P., Blanda M., Gerson L., DeJulius A., and Rajaratnam M. Comparison of intramuscular tramcionlone and oral prednisone in the outpatient treatment of acute asthma: a randomized controlled trial. Ann Emerg Med 31 (1998) 333-338
12. Lahn M., Bijur P., and Gallagher E.J. Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest 126 (2004) 362-368
13. Nana A., Youngchaiyud P., Charoenratanakul S., Boe J., Lofdahl C.G., Selroos O., et al. High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attack. J Asthma 35 (1998) 647-655
14. Fitzgerald J.M., Shragge D., Haddon J., Jennings B., Lee J., Bai T., et al. A randomized, controlled trial of high dose, inhaled budesonide versus oral prednisone in patients discharged from the emergency department following an acute asthma exacerbation. Can Respir J 7 (2000) 61-67
15. Rowe B.H., Bota G.W., Fabris L., Therrien S.A., Milner R.A., and Jacono J. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department. A randomized clinical trial. JAMA 281 (1999) 2119-2126
16. Brenner B.E., Chavda K.K., and Camargo Jr. C.A. Randomized trial of inhaled flunisolide versus placebo among asthmatic patients discharged from the emergency department. Ann Emerg Med 36 (2000) 417-426
17. Camargo C Jr. on behalf of the MARC investigators. Randomized trial of medium dose flunisolide vs. placebo after an emergency department visit for acute asthma. Presented at: Asthma & Immunology 56th Annual Meeting. San Diego, CA: American Academy of Allergy; 2000.
18. Johnston S.L., Blasi F., Black M.B., Martin R.J., Farrell D.J., Nieman R.B., et al. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 354 (2006) 1589-1600
19. Williams L.K., Pladevall M., Xi H., Peterson E.L., Joseph C., Lafata J.E., et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 114 (2004) 1288-1293
20. Camargo C.A., Ramanchandran S., Ryskina K.L., Lewis B.E., and Legorreta A.P. Association between common asthma therapies and recurrent asthma exacerbations in children enrolled in a state Medicaid plan. Am J Health Syst Pharm 64 (2007) 1054-1061
21. Butler K., and Cooper W.O. Adherence of pediatric asthma patients with oral corticosteroid prescriptions following emergency department visit or hospitalization. Pediatr Emerg Care 20 (2004) 730-735
22. Krishnan J.A., Riekert K.A., McCoy J.V., Stewart D.Y., Schmidt S., Chanmugam A., et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med 170 (2004) 1281-1285
23. Cooper W.O., and Hickman G.B. Corticosteroid prescription filling for children covered by Medicaid following an emergency department visit or hospitalization for asthma. Arch Pediatr Adolesc Med 155 (2001) 1111-1115
24. Adams N., Bestall J., and Jones P.W. Budesonide versus placebo for chronic asthma in children and adults. Cochrane Database Syst Rev 4 (1999) CD003274. DOI:10.1002/14651858.CD003274
25. Smith M.J., Rascati K.L., and McWilliams B.C. Inhaled anti-inflammatory pharmacotherapy and subsequent hospitalizations and emergency department visits among patients with asthma in the Texas Medicaid program. Ann Allergy Asthma Immunol 92 (2004) 40-46
26. Sin D.D., and Man S.F.P. Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Intern Med 162 (2002) 1591-1595
27. Salerno E.L., Wolf S., Troy P., Horowitz S., Banever A., Metersky M., et al. Discharge patterns of patients with asthma from the emergency department: a retrospective review. Conn Med 69 (2005) 621-627
28. Scarfone R.J., Zorc J.J., and Angsuco C.J. Emergency physicians' prescribing of asthma controller medications. Pediatrics 117 (2006) 821-827
29. Cydulka R.K., Tamayo-Sarver J.H., Wolf C., Herrick E., and Gress S. Inadequate follow-up controller medications among patients with asthma who visit the emergency department. Ann Emerg Med 46 (2005) 316-322
30. National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. http://www.nhlbi.nih.gov/guidelines/asthma/index.htm Accessed May 30, 2009
31. Shrestha M., Parupia H., Andrews B., Kim S.W., Martin M.S., Park D.I., et al. Metered-dose inhaler technique of patients in an urban ED: prevalence of incorrect technique and attempt at education. Am J Emerg Med 14 (1996) 380-384
32. Numata Y., Bourbeau J., Ernst P., Duquette G., and Schwarzman K. Teaching time for metered-dose inhalers in the emergency setting. Chest 122 (2002) 498-504
33. Paasche-Orlow M.K., Riekert K.A., Bilderback A., Chanmugam A., Hilll P., Rand C.S., et al. Tailored education may reduce health literacy disparities in asthma self-management. Am J Respir Crit Care Med 172 (2005) 980-986
34. Healy D.P. Macrolide immunomodulation of chronic respiratory diseases. Curr Infect Dis Rep 9 (2007) 7-13
35. US Food and Drug Administration. Telithromycin (marketed as Ketek) information. http://www.fda.gov/cder/drug/infopage/telithromycin/default.htm Accessed May 30, 2009
36. Weiss J.W., Drazen J.M., Coles N., McFadden Jr. E.R., Weller P.F., Corey E.J., et al. Bronchoconstrictor effects of leukotriene C in humans. Science 216 (1982) 196-198
37. Taylor G.W., Taylor I., Black P., Maltby N.H., Turner N., Fuller R.W., et al. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet 1 (1989) 584-588